Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1101)
  2. Meeting Abstract (898)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2173)
  2. Department of Medicine (2167)
  3. Gynecology Disease Management Team (1870)
  4. GDMT, Medicine (1852)
  5. Surgery (600)
  6. GDMT, Surgery (477)

More Groups

People
  1. Carol Aghajanian (613)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (267)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (68)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (158)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (70)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (544)
  2. American Society of Clinical Oncology (498)
  3. Lippincott Williams & Wilkins (185)
  4. American Association for Cancer Research (172)
  5. Oxford University Press (143)
  6. Nature Publishing Group (88)

More Publishers

Results (2173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
    Journal Article

    Liu, J. F.; Colombo, N.; Oza, A. M.; Frenel, J. S.; Corr, B. R.; Rubinstein, M. M.; Nevadunsky, N. S.; Lheureux, S.; Gaba, L.; González Cortijo, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Neoplasia detection via colonic surveillance among young individuals with MSH6 and PMS2 -associated Lynch Syndrome
    Journal Article

    Latham, A.; Liu, Y. L.; Constantino, G.; Borio, M.; McCoy, S.; Dudzik, C.; Heiman, J.; Kemel, Y.; Ukaegbu, C.; Carlo, M. I.; more...
    American Journal of Gastroenterology (2025)

    Fulltext@MSK | Save
  • Repurposing Food and Drug Administration-approved cancer therapies: Exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment
    Review

    Podder, V.; Grisham, R. N.; Coleman, R. L.; Cobb, L. P.; Monk, B. J.; Herzog, T. J.; Gershenson, D. M.; Slomovitz, B. M.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Therapeutic targeting of mismatch repair-deficient cancers
    Review

    Johannet, P.; Rousseau, B.; Aghajanian, C.; Foote, M. B.; Diaz, L. A. Jr
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
    Journal Article

    McPherson, A.; Vázquez-García, I.; Myers, M. A.; Al-Rawi, D. H.; Zatzman, M.; Weiner, A. C.; Freeman, S.; Mohibullah, N.; Satas, G.; Williams, M. J.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib ± defactinib in recurrent low-grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
    Journal Article

    Banerjee, S. N.; Van Nieuwenhuysen, E.; Aghajanian, C.; D'Hondt, V.; Monk, B. J.; Clamp, A.; Prendergast, E.; Oaknin, A.; Ring, K.; Colombo, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Comprehensive molecular, pathological, and clinical characterization of clear cell adenocarcinoma of the urinary tract
    Journal Article

    Rammal, R.; Koll, F. J.; Chen, Z.; Tallman, J. E.; Alam, S. M.; Eichholz, J. E.; Chatila, W.; Agbamu, T.; Lenis, A. T.; Basar, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Oral mucositis associated with antibody-drug conjugates in gynecologic oncology: Strategies for prevention and treatment
    Review

    Lightfoot, M. D. S.; Rubinstein, M. M.; Monk, B. J.; Eskander, R. N.; Lutz, K.; Moore, K. N.; Herzog, T. J.; Pothuri, B.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save